Cargando…

Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention

Contrast media-induced nephropathy (CIN) is a well-known complication of radiological examinations employing iodine contrast media (I-CM). The rapid development and frequent use of coronary interventions and multi-channel detector computed tomography with concomitant administration of relatively lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterner, Gunnar, Nyman, Ulf
Formato: Texto
Lenguaje:English
Publicado: CoAction Publishing 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078203/
https://www.ncbi.nlm.nih.gov/pubmed/21503209
http://dx.doi.org/10.4176/070402
_version_ 1782201926072401920
author Sterner, Gunnar
Nyman, Ulf
author_facet Sterner, Gunnar
Nyman, Ulf
author_sort Sterner, Gunnar
collection PubMed
description Contrast media-induced nephropathy (CIN) is a well-known complication of radiological examinations employing iodine contrast media (I-CM). The rapid development and frequent use of coronary interventions and multi-channel detector computed tomography with concomitant administration of relatively large doses of I-CM has contributed to an increasing number of CIN cases during the last few years. Reduced renal function, especially when caused by diabetic nephropathy or renal arteriosclerosis, in combination with dehydration, congestive heart failure, hypotension, and administration of nephrotoxic drugs are risk factors for the development of CIN. When CM-based examinations cannot be replaced by other techniques in patients at risk of CIN, focus should be directed towards analysis of number and type of risk factors, adequate estimation of GFR, institution of proper preventive measures including hydration and post-procedural observation combined with surveillance of serum creatinine for 1-3 days. For the radiologist, there are several steps to consider in order to minimise the risk for CIN: use of “low-“ or “iso-osmolar” I-CM and dosing the I-CM in relation to GFR and body weight being the most important as well as utilizing radiographic techniques to keep the I-CM dose in gram iodine as low as possible below the numerical value of estimated GFR. There is as yet no pharmacological prevention that has been proven to be effective.
format Text
id pubmed-3078203
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher CoAction Publishing
record_format MEDLINE/PubMed
spelling pubmed-30782032011-04-18 Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention Sterner, Gunnar Nyman, Ulf Libyan J Med Review Article Contrast media-induced nephropathy (CIN) is a well-known complication of radiological examinations employing iodine contrast media (I-CM). The rapid development and frequent use of coronary interventions and multi-channel detector computed tomography with concomitant administration of relatively large doses of I-CM has contributed to an increasing number of CIN cases during the last few years. Reduced renal function, especially when caused by diabetic nephropathy or renal arteriosclerosis, in combination with dehydration, congestive heart failure, hypotension, and administration of nephrotoxic drugs are risk factors for the development of CIN. When CM-based examinations cannot be replaced by other techniques in patients at risk of CIN, focus should be directed towards analysis of number and type of risk factors, adequate estimation of GFR, institution of proper preventive measures including hydration and post-procedural observation combined with surveillance of serum creatinine for 1-3 days. For the radiologist, there are several steps to consider in order to minimise the risk for CIN: use of “low-“ or “iso-osmolar” I-CM and dosing the I-CM in relation to GFR and body weight being the most important as well as utilizing radiographic techniques to keep the I-CM dose in gram iodine as low as possible below the numerical value of estimated GFR. There is as yet no pharmacological prevention that has been proven to be effective. CoAction Publishing 2007-09-01 /pmc/articles/PMC3078203/ /pubmed/21503209 http://dx.doi.org/10.4176/070402 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sterner, Gunnar
Nyman, Ulf
Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
title Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
title_full Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
title_fullStr Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
title_full_unstemmed Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
title_short Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
title_sort contrast medium-induced nephropathy. aspects on incidence, consequences, risk factors and prevention
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078203/
https://www.ncbi.nlm.nih.gov/pubmed/21503209
http://dx.doi.org/10.4176/070402
work_keys_str_mv AT sternergunnar contrastmediuminducednephropathyaspectsonincidenceconsequencesriskfactorsandprevention
AT nymanulf contrastmediuminducednephropathyaspectsonincidenceconsequencesriskfactorsandprevention